Boron Molecular, DMTC, CSIRO demonstrate flow chemistry production of pharmaceuticals

Technology

A partnership with its origins in the Covid-19 lockdowns and supply chain disruptions of 2020 has reported progress, successfully demonstrating at pilot scale a continuous flow chemistry-based platform for producing pharmaceuticals. According to a statement from DMTC on Thursday, the work so far had successfully demonstrated the scalability of the platform, which is based on…

BioCina aims for vaccines against biowarfare threats

Defence, Manufacturing News, Technology

Pharmaceutical and vaccine manufacturer BioCina is industry partner in an ambitious research project that aims to develop vaccine candidates to protect against biowarfare threats including Q Fever, tularaemia, and melioidosis. BioCina, the health Security Systems Australia (HSSA) division of defence innovation group DMTC, and academics led by Griffith University, including the Australian Rickettsial Reference Laboratory…